Details
Stereochemistry | ACHIRAL |
Molecular Formula | C9H15NO |
Molecular Weight | 153.2215 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CN1[C@H]2CCC[C@@H]1CC(=O)C2
InChI
InChIKey=RHWSKVCZXBAWLZ-OCAPTIKFSA-N
InChI=1S/C9H15NO/c1-10-7-3-2-4-8(10)6-9(11)5-7/h7-8H,2-6H2,1H3/t7-,8+
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: amyloid beta-protein (1-40) Sources: https://www.ncbi.nlm.nih.gov/pubmed/19715547 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseUnknown |
PubMed
Title | Date | PubMed |
---|---|---|
Dolasetron overdose resulting in prolonged QTc interval and severe hypotension: a case report and literature review. | 2007 Jul |
|
Association constants of pyridine and piperidine alkaloids to amyloid beta peptide determined by electrochemical impedance spectroscopy. | 2010 Mar |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: http://www.guidechem.com/dictionary/552-70-5.html
Guinea pig: LDLo - subcutaneous, 230 mg/kg
Route of Administration:
Other
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/22163834
Binding to Abeta(1-40) of pseudopelletierine was (0.57 x 10(8) M(-1)
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
209-021-1
Created by
admin on Sat Dec 16 10:07:19 GMT 2023 , Edited by admin on Sat Dec 16 10:07:19 GMT 2023
|
PRIMARY | |||
|
USN3FV3Z9X
Created by
admin on Sat Dec 16 10:07:19 GMT 2023 , Edited by admin on Sat Dec 16 10:07:19 GMT 2023
|
PRIMARY | |||
|
6602484
Created by
admin on Sat Dec 16 10:07:19 GMT 2023 , Edited by admin on Sat Dec 16 10:07:19 GMT 2023
|
PRIMARY | |||
|
116056
Created by
admin on Sat Dec 16 10:07:19 GMT 2023 , Edited by admin on Sat Dec 16 10:07:19 GMT 2023
|
PRIMARY | |||
|
DTXSID20870606
Created by
admin on Sat Dec 16 10:07:19 GMT 2023 , Edited by admin on Sat Dec 16 10:07:19 GMT 2023
|
PRIMARY | |||
|
Pseudopelletierine
Created by
admin on Sat Dec 16 10:07:19 GMT 2023 , Edited by admin on Sat Dec 16 10:07:19 GMT 2023
|
PRIMARY | |||
|
552-70-5
Created by
admin on Sat Dec 16 10:07:19 GMT 2023 , Edited by admin on Sat Dec 16 10:07:19 GMT 2023
|
PRIMARY | |||
|
m9298
Created by
admin on Sat Dec 16 10:07:19 GMT 2023 , Edited by admin on Sat Dec 16 10:07:19 GMT 2023
|
PRIMARY | Merck Index | ||
|
8607
Created by
admin on Sat Dec 16 10:07:19 GMT 2023 , Edited by admin on Sat Dec 16 10:07:19 GMT 2023
|
PRIMARY |
SUBSTANCE RECORD